Complement factor H and hemolytic uremic syndrome

International Immunopharmacology

Volumn 1, Issue 3, 2001, Pages 461-468

  Zipfel, Peter F ^a,b   Skerka, Christine ^a,b   Caprioli, Jessica ^c   Manuelian, Tamara ^a,b   Neumann, Hartmut H ^d   Noris, Marina ^c   Remuzzi, Giuseppe ^b,c  

^a HANS KNÖLL INSTITUTE   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Factor H; Hemolytic uremic syndrome; Short concensus repeats

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H;

ACUTE KIDNEY FAILURE; CANCER; CARBOXY TERMINAL SEQUENCE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT BLOOD LEVEL; COMPLEMENT DEFICIENCY; COMPLEMENT SYSTEM; CONFERENCE PAPER; CONSENSUS SEQUENCE; DISEASE ASSOCIATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFECTION SENSITIVITY; KIDNEY CIRCULATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

COMPLEMENT FACTOR H; COMPLEMENT SYSTEM PROTEINS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MUTATION; PROTEIN STRUCTURE, TERTIARY;

EID: 0035093956     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(00)00047-3     Document Type: Conference Paper

References (37)

1. Analysis of the human regulators of complement activation (RCA) gene cluster with yeast artificl chromosoemes (YACs)
2. Complement factor H and related proteins: An expanding family of complement-regulatory proteins?
3. Factor H and disease: A complement regulator affects vital body functions
4. Isolation of b1F-globulin from human serum and its characterization as the fifth component of complement
5. Distinct regulation of human factor H gene products: Extrahepatic sources and regulation during inflammation and rheumatoid arthritis
6. Human complement C3b inactivator: Isolation, characterization, and demonstration of an absolute requirement for the serum protein β1H for cleavage of C3b and C4b in solution
7. Modulation of the alternative complement pathway by β1Hglobulin
8. Discrimination between activator and nonactivators of the alternative pathway of complement: Regulation via sialic acid/polyanion binding sites on factor H
9. Each of the three binding sites on factor H interacts with a distinct site on C3b
10. The C-terminus of Factor-H: Monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteins
11. Ultrastructures and interactions of complement factor H and I
12. Human complement regulators: A major target for pathogenic microorganisms
13. Immune evasion of tumor cells using membrane-bound complement regulatory proteins
14. Resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1
15. Human factor H deficiency: Mutations in framework cysteine residues block H protein secretion and intracellular catabolism
16. Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency
17. Nephritogenic lambda-light chain dimer: A unique human miniautoantibody against complement factor H
18. Activation of the alternative pathway of complement by monoclonal 1 light chains in membranoproliferative glomerulonephritis
19. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: A tool for the diagnosis of thrombotic thrombocytopenic purpura
20. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
21. The hemolytic uremic syndrome
22. Inherited hemolytic uremic syndrome in adults
23. Thrombotic microangiopathy
24. Hemolytic uremic syndrome in families
25. Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor
26. Hypocomplementaemia due to a genetic deficiency of β1H globulin
27. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum
28. Biologic consequences of complement activation
29. Hypocomplementemia discloses genetic predisposition to haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura: Role of factor H abnormalities
30. Familial hemolytic-uremic syndrome and homozygous factor H deficiency
31. Human complement Factor H deficiency associated with hemolytic uremic syndrome
32. Genetic studies into inherited and sporadic hemolytic uremic syndrome
33. Mutations of factor H (HF) in familial hemolytic uremic syndrome (HUS)/thrombotic thrombocytopenic purpura (TTP)
34. Factor H-US?
35. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome
36. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Letter to the Editor
37. Three new polymorphisms in the human complement factor H gene and promoter region